“We’re at a transformative moment in the biomedical sciences,” says James Lu, an AI scientist at the Agency for Science, Technology and Research Bioinformatics Institute (A*STAR BII) in Singapore.

Cleared by the FDA in 2024, the test gained real-world traction in 2025 when it was incorporated into a new global framework ...